Ham A, Lin S, Tse A, Thurkauf M, McGowan T, Jorin L
Nat Commun. 2025; 16(1):2220.
PMID: 40044687
PMC: 11882927.
DOI: 10.1038/s41467-025-57487-1.
Choe Y, Das S, Ma X, Lee H, Sorensen J, Hoffman D
Commun Biol. 2025; 8(1):217.
PMID: 39934347
PMC: 11814088.
DOI: 10.1038/s42003-025-07648-1.
Lim J, Jensen S, Plomp J, Vankerckhoven B, Kneip C, Coppejans R
iScience. 2025; 28(2):111684.
PMID: 39898046
PMC: 11783450.
DOI: 10.1016/j.isci.2024.111684.
Keritam O, Vincent A, Zimprich F, Cetin H
Front Immunol. 2024; 15:1502480.
PMID: 39703505
PMC: 11655327.
DOI: 10.3389/fimmu.2024.1502480.
Barden J, Kosloski O, Jadidian A, Akaaboune M
J Cell Sci. 2024; 137(24).
PMID: 39575567
PMC: 11795291.
DOI: 10.1242/jcs.262303.
Acute high-intensity muscle contraction moderates AChR gene expression independent of rapamycin-sensitive mTORC1 pathway in rat skeletal muscle.
Makanae Y, Ato S, Kouzaki K, Tamura Y, Nakazato K
Exp Physiol. 2024; 110(1):127-146.
PMID: 39501426
PMC: 11689120.
DOI: 10.1113/EP091006.
Postsynaptic BMP signaling regulates myonuclear properties in Drosophila larval muscles.
von Saucken V, Windner S, Armetta G, Baylies M
J Cell Biol. 2024; 224(1).
PMID: 39475469
PMC: 11530350.
DOI: 10.1083/jcb.202404052.
Age-Related Homeostatic Plasticity at Rodent Neuromuscular Junctions.
Li Y, Badawi Y, Meriney S
Cells. 2024; 13(20.
PMID: 39451202
PMC: 11506802.
DOI: 10.3390/cells13201684.
Agonist antibody to MuSK protects mice from MuSK myasthenia gravis.
Oury J, Gamallo-Lana B, Santana L, Steyaert C, Vergoossen D, Mar A
Proc Natl Acad Sci U S A. 2024; 121(39):e2408324121.
PMID: 39288173
PMC: 11441477.
DOI: 10.1073/pnas.2408324121.
Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A
Signal Transduct Target Ther. 2024; 9(1):201.
PMID: 39138146
PMC: 11323831.
DOI: 10.1038/s41392-024-01899-w.
A conserved RNA switch for acetylcholine receptor clustering at neuromuscular junctions in chordates.
Hossain M, Popsuj S, Vitrinel B, Kaplan N, Stolfi A, Christiaen L
bioRxiv. 2024; .
PMID: 39005407
PMC: 11245090.
DOI: 10.1101/2024.07.05.602308.
Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease.
Hu L, Chen W, Qian A, Li Y
Bone Res. 2024; 12(1):39.
PMID: 38987555
PMC: 11237130.
DOI: 10.1038/s41413-024-00342-8.
Spatial transcriptomics in embryonic mouse diaphragm muscle reveals regional gradients and subdomains of developmental gene expression.
Kaplan M, Zeidler M, Knapp A, Holzl M, Kress M, Fritsch H
iScience. 2024; 27(6):110018.
PMID: 38883818
PMC: 11177202.
DOI: 10.1016/j.isci.2024.110018.
Effects of physical exercise on neuromuscular junction degeneration during ageing: A systematic review.
Wang Q, Cui C, Zhang N, Lin W, Chai S, Chow S
J Orthop Translat. 2024; 46:91-102.
PMID: 38817243
PMC: 11137388.
DOI: 10.1016/j.jot.2024.03.007.
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.
Koneczny I, Mane-Damas M, Zong S, de Haas S, Huda S, van Kruining D
Front Immunol. 2024; 15:1325171.
PMID: 38715598
PMC: 11074957.
DOI: 10.3389/fimmu.2024.1325171.
Postsynaptic BMP signaling regulates myonuclear properties in larval muscles.
von Saucken V, Windner S, Baylies M
bioRxiv. 2024; .
PMID: 38645063
PMC: 11030338.
DOI: 10.1101/2024.04.10.588944.
Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.
He T, Chen K, Li Y, Luo Z, Luo M, Yang H
Neuropsychiatr Dis Treat. 2024; 20:725-735.
PMID: 38566882
PMC: 10986406.
DOI: 10.2147/NDT.S450651.
Calcium-binding protein 7 expressed in muscle negatively regulates age-related degeneration of neuromuscular junctions in mice.
Eguchi T, Tezuka T, Watanabe Y, Inoue-Yamauchi A, Sagara H, Ozawa M
iScience. 2024; 27(2):108997.
PMID: 38327785
PMC: 10847746.
DOI: 10.1016/j.isci.2024.108997.
Myosin Va: Capturing cAMP for synaptic plasticity.
Rudolf R
Front Physiol. 2024; 14:1342994.
PMID: 38239886
PMC: 10794446.
DOI: 10.3389/fphys.2023.1342994.
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies.
Iorio R
Nat Rev Neurol. 2024; 20(2):84-98.
PMID: 38191918
DOI: 10.1038/s41582-023-00916-w.